Table 5.
Overall survival | Patients with events, n (%) | Event-free rate at 5 years (95% CI) |
---|---|---|
Overall population, N = 2573 | 2395 (93.1) | 93.5% (92.4%– 94.4%) |
No chemotherapy, n = 235 | 12 (5.1) | 95.5% (91.5%–97.6%) |
Concurrent chemotherapy, n = 1533 | 98 (6.4) | 94.4% (93.0%–95.5%) |
Sequential chemotherapy, n = 805 | 68 (8.4) | 91.2% (88.9%–93.1%) |
ITT, intent-to-treat.